Sydney Adventist Hospital ranked one of worlds top hospitals for oncology in Newsweek 2022 survey
Sydney Adventist Hospital ranked one of world’s top hospitals for oncology in Newsweek 2022 survey.
Sydney Adventist Hospital has been listed amongst Newsweek’s World’s Best Specialized Hospitals 2022 report in the area of oncology – the core of which is the San Integrated Cancer Centre.
The Newsweek ranking features the top 250 hospitals for cardiology and oncology, the top 150 for cardiac surgery and paediatrics and the top 125 each in endocrinology, gastroenterology, orthopaedics, neurology, neurosurgery and pulmonology.
The research included 25 countries and was conducted by market research company Statista in partnership with Newsweek. Data was gathered from three sources: recommendations by doctors via an online survey from the 25 countries; publicly available patient satisfaction survey results; and publicly available medical KPIs on hospitals.
Associate Professor Gavin Marx, Clinical Director, San Integrated Cancer Centre, said that the Hospital is delighted with the news.
“Over many years, we have developed a high-volume cancer service at the San that incorporates the use of advanced technology with an extremely empathetic approach that treats each patient with unique, individualised care,” he said.
"We offer a rapid access model including the best available diagnostic assessment and senior specialist consultation. It's clear that our highly skilled team, along with constant innovation, has led to excellent patient outcomes and our impressive reputation both in Australia and internationally.”
Key elements of the integrated and multidisciplinary Centre include state-of-the-art imaging, a full range of high-quality surgical and reconstructive services, comprehensive medical oncology services, expert onsite cancer genetics and extensive cancer support services.
The co-located Icon Cancer Centre provides the latest in radiation therapy technology and techniques for all cancer types.
To provide patients with novel medical therapies, the Centre’s Clinical Trials Unit participates in international trials in breast, colorectal, prostate, melanoma and other cancers.
The Hospital is also known for its highly engaged patient navigators, who support patients at every point during their time with the San.
CEO Brett Goods says he is extremely proud of the excellent work of the San’s cancer teams and their recognition in an international context.
"The Newsweek ranking builds on the San being noted as an oncology leader in local rankings," said Mr Goods. "In 2020, for the third consecutive year, the San Integrated Cancer Centre achieved some of the highest ratings in the Bureau of Health Information patient survey, conducted in partnership with the Cancer Institute of NSW."
Back to News